Last updated: May 17, 2016
|CMS Measure ID:||CMS108v3|
This measure assesses the number of patients who received VTE prophylaxis or have documentation why no VTE prophylaxis was given the day of or the day after hospital admission or surgery end date for surgeries that start the day of or the day after hospital admission.
|Initial Patient Population:||
Patients age 18 and older discharged from hospital inpatient acute care with a diagnosis of venous thromboembolism (VTE) and a length of stay less than or equal to 120 days.
All patients in the initial patient population
Patients who received VTE prophylaxis or have documentation why no VTE prophylaxis was given:
|Measure Steward:||The Joint Commission|
|Next Version:||Venous Thromboembolism Prophylaxis|
An increase in rate
The unit of measurement for this measure is an inpatient episode of care. Each distinct hospitalization should be reported, regardless of whether the same patient is admitted for inpatient care more than once during the measurement period. In addition, the eMeasure logic intends to represent events within or surrounding a single occurrence of an inpatient hospitalization.
When low dose unfractionated heparin is not administered due to medical reasons, the intended administration route is subcutaneous.
The construct of Unfractionated Heparin (route: 'Intravenous route') intends to capture continually infused heparin rather than heparin flushes or pushes.